Mesothelioma Blog » malignant pleural mesothelioma

Extrapleural Pneumonectomy Extends Survival for Malignant Mesothelioma

CPSM — Tue, 09 Aug 2011 23:09:45 +0000

Results from recent research, led by David J. Sugarbaker, M.D., show that patients suffering from malignant pleural mesothelioma (MPM) have much higher chance of longer survival when they undergo extrapleural pneumonectomy (EPP). Sugarbaker is one of the most experienced thoracic surgeons specializing in the treatment of mesothelioma. He currently performs surgery at Brigham and Women’s [...]

Extrapleural Pneumonectomy Extends Survival for Malignant Mesothelioma is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Clinical Trail Investigates Use of Palliative Care with Mesothelioma Patients

CPSM — Wed, 23 Mar 2011 22:43:27 +0000

Janet L. Abrahm, M.D. is co-investigator with David Sugerbaker on a study exploring the impact of bi-weekly palliative care assessment with patients diagnosed with malignant pleural mesothelioma. This investigation is part of a larger study led by Dr. Alice Kornblith, a senior research assistant at the Dana-Farber Cancer Institute. The study’s aim is to enroll [...]

Clinical Trail Investigates Use of Palliative Care with Mesothelioma Patients is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Federal Court Protects Alimta Against Generic Competitor

CPSM — Tue, 28 Dec 2010 17:26:23 +0000

Eli Lilly & Co. has won its case in Federal court in Delaware where it sought to protect its patent for the drug Alimta. Alimta (pemetrexed for injection) now marketed by Eli Lilly & Co. (“Lilly”) was developed in clinical trials by Lilly in the early 1990s after it was discovered that disodium pemetrexed, the [...]

Federal Court Protects Alimta Against Generic Competitor is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Alimta – The Cancer Drug for Treating Mesothelioma

CPSM — Tue, 11 May 2010 15:18:02 +0000

Alimta, also known as pemetrexed if given by injection, is the standard chemotherapy drug given to patients diagnosed with mesothelioma, a rare form of cancer caused by exposure to asbestos. Alimta was discovered by Edward Taylor, a chemist at Princeton University. Mesothelioma is a rare form of cancer that begins in the mesothelium, which is the [...]

Alimta – The Cancer Drug for Treating Mesothelioma is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Search for Treatment and Cure for Mesothelioma

CPSM — Wed, 14 Apr 2010 14:51:56 +0000

The incidence of mesothelioma continues to rise through out the world. Mesothelioma is an aggressive cancer that forms in the lining of the lungs, heart and abdomen. The primary risk factor for mesothelioma is exposure to asbestos. Despite this known and scientifically proven fact, the use of asbestos still continues in developing countries, without any [...]

Search for Treatment and Cure for Mesothelioma is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Front and Second Line Treatments for Mesothelioma

CPSM — Sun, 07 Feb 2010 22:06:16 +0000

If you or someone you know has been diagnosed with malignant mesothelioma, you are probably trying to understand which treatments might be most effective. If you have gone through initial treatment with little results, you may be exploring what other options you have. Recently medical researchers published an article in Cancer Treatment Reviews (February 2010) with a [...]

Front and Second Line Treatments for Mesothelioma is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.

Mesothelioma Treatments: Immunotherapy

CPSM — Fri, 27 Mar 2009 23:15:52 +0000

Mesothelioma is an incurable, aggressive cancer primarily caused by exposure to asbestos. It is a disease that starts in the lining of the cells in the lungs or abdomen. There are three types of mesothelioma: Pleural Mesothelioma, which occurs in the lining of the lung; Peritoneal Mesothelioma, which occurs in the lining of the abdominal cavity; Pericardial Mesothelioma, which [...]

Mesothelioma Treatments: Immunotherapy is a post from: Mesothelioma Blog, the official blog of Clapper, Patti, Schweizer & Mason mesothelioma attorneys with more than 25 years experience helping clients.